Published in Medical Letter on the CDC and FDA, December 3rd, 2006
These strategies were identified and evaluated as part of a strategic review begun in January 2006 at the request of the company's board of directors and with the assistance of Piper Jaffray & Co.
The board has directed management to actively pursue the following three strategies:
- Identify and evaluate acquisition opportunities of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA